首页行业分类生物医药生物2023-04-03-西南证券-瑞普生物-多板块稳健经营,创新研发促成长
PDF

2023-04-03-西南证券-瑞普生物-多板块稳健经营,创新研发促成长

后*****64页1.12M

下载文档
/4
全屏查看
2023-04-03-西南证券-瑞普生物-多板块稳健经营,创新研发促成长
还有 4 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 4 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
瑞普生物(300119)2022年报底评2022A2023E2024E2025E2022A2023E2024E2025E2084.252406.952827.583351.82373.77601.32743.66917.04营业成本1074.611086.401253.901463.95折旧与摊销108.04121.99121.99121.99营业税金及册加20.4023.0627.2332.3117.3511.675.971.10销售货用344.07397.15452.41519.530.470.000.000.00142.82324.94367.58435.74经营营运黄本变动281.16-181.40-136.41-160.44财务货用17.3511.675.971.10其他-391.31-13.94-118.39-123.550.470.000.000.00389.49539.63616.82756.134.0515.0015.0020.00.399.440.000.000.0051.38100.00100.00110.00-845.29826.1342.9389.18其他经营损益0.000.000.000.00-1244.73826.1342.9389.18416.64678.74835.481029.19短期借款75.59-17.69.161.86228.37-2834.07-4.45-4.64长期猎款101.050.000.000.00413.81674.67831.031024.5520.070.000.000.00所得税40.0473.3587.37107.51支付股利-163.69-137.49-218.50-275.08373.77601.32743.66917.0441.22-30.48-5.97-1.1027.0750.3350.0060.0048.35-185.66-386.33-504.55346.70550.99693.66857.04.903.551180.09273.41340.762022A2023E2024E2025E2022A2023E2024E2025E384.421564.521837.922178.68成长能力应收和预付款项803.81825.14999.961190.963.84%15.48%17.48%18.54%存货367.06370.24427.54499.38-16.57%62.91%23.09%23.19%其他流动黄产1538.00817.43893.95943.12-13.80%60.88%23.67%23.31%377.49377.49377.49377.49BTDA增长率-10.03%49.88%18.59%19.60%46.9850.9852.0750.631561.781448.921336.061223.19毛利率48.44%54.86%55.65%56.32%无彩资产和开发支出469.04460.01450.97441.9424.19%30.48%29.21%28.53%557.69557.60557.51557.4217.93%24.98%26.30%27.36%6106.276472.306933.477462.82ROE8.30%12.11%13.55%14.95%666.71649.01487.15258.78ROA6.12%9.29%10.73%12.29%499.19449.12535.84630.92ROIC10.68%15.58%18.01%20.44%长期借款191.18191.18191.18191.1826.01%33.75%34.07%34.38%248.10218.06229.20249.891605.171507.371443.381330.770.350.380.420.47股本468.02468.02468.02468.022.102.132.783.702202.942202.942202.942202.942.873.073.113.11留存收益1591.702005.212480.363062.33存货周转率2.952.943.143.154221.514635.015110.175692.1393.61%279.59329.92379.92439.924501.104964.935490.096132.0526.29%23.29%20.82%17.83%6106.276472.306933.477462.82带息债务感负债53.45%55.74%47.00%33.81%流动比率2.362.953.624.652022A2023E2024E2025E速动比率2.082.653.254.17EBITDA542.03812.39963.441152.28股利支付率47.22%24.95%31.50%32.10%PE29.2118.3814.6011.822252.041.841.650.741.181.481.83PS4.864.213.583.029.6210.6111.7313.10EV/EBITDA15.549.737.685.89每股经营现金0.831.151.321.621.62%1.36%2.16%2.72%每股股利0.350.290.470.59请务必阅读正文后的重要声明部分